| Symbol |
Name |
|
AAGAB
|
alpha- and gamma-adaptin binding protein
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAN
|
aggrecan
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALX3
|
ALX homeobox 3
|
|
ALX4
|
ALX homeobox 4
|
|
ANTXR2
|
anthrax toxin receptor 2
|
|
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ARHGAP26
|
Rho GTPase activating protein 26
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ASCC1
|
activating signal cointegrator 1 complex subunit 1
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AXIN1
|
axin 1
|
|
AXIN2
|
axin 2
|
|
B3GALT6
|
UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLNK
|
B-cell linker
|
|
BMPER
|
BMP binding endothelial regulator
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
BUB3
|
BUB3 mitotic checkpoint protein
|
|
CALR
|
calreticulin
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CC2D2A
|
coiled-coil and C2 domain containing 2A
|
|
CCBE1
|
collagen and calcium binding EGF domains 1
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCND1
|
cyclin D1
|
|
CD19
|
CD19 molecule
|
|
CD27
|
CD27 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD81
|
CD81 molecule
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK11B
|
cyclin-dependent kinase 11B
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEP57
|
centrosomal protein 57kDa
|
|
CES1
|
carboxylesterase 1
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRNG
|
cholinergic receptor, nicotinic, gamma (muscle)
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL14A1
|
collagen, type XIV, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL5A2
|
collagen, type V, alpha 2
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COX1
|
|
|
COX2
|
|
|
COX3
|
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTC1
|
CTS telomere maintenance complex component 1
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSA
|
cathepsin A
|
|
CTSC
|
cathepsin C
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DEC1
|
deleted in esophageal cancer 1
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DHH
|
desert hedgehog
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIRC2
|
disrupted in renal carcinoma 2
|
|
DIS3L2
|
DIS3 like 3'-5' exoribonuclease 2
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DPM1
|
dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECM1
|
extracellular matrix protein 1
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ENG
|
endoglin
|
|
EP300
|
E1A binding protein p300
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
|
ETV1
|
ets variant 1
|
|
ETV6
|
ets variant 6
|
|
EVC
|
Ellis van Creveld protein
|
|
EVC2
|
Ellis van Creveld syndrome 2
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase)
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCE
|
Fanconi anemia, complementation group E
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FANCI
|
Fanconi anemia, complementation group I
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FERMT1
|
fermitin family member 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FH
|
fumarate hydratase
|
|
FLCN
|
folliculin
|
|
FLNA
|
filamin A, alpha
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOXC2
|
forkhead box C2
|
|
FOXI1
|
forkhead box I1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO4
|
forkhead box O4
|
|
FOXP1
|
forkhead box P1
|
|
FUS
|
FUS RNA binding protein
|
|
FUZ
|
fuzzy planar cell polarity protein
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
GABRD
|
gamma-aminobutyric acid (GABA) A receptor, delta
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GDF2
|
growth differentiation factor 2
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GFI1B
|
growth factor independent 1B transcription repressor
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB3
|
gap junction protein, beta 3, 31kDa
|
|
GJB4
|
gap junction protein, beta 4, 30.3kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLI3
|
GLI family zinc finger 3
|
|
GMPS
|
guanine monphosphate synthase
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNPTAB
|
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
|
|
GOLGA5
|
golgin A5
|
|
GPC3
|
glypican 3
|
|
GPC4
|
glypican 4
|
|
GPC6
|
glypican 6
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBB
|
hemoglobin, beta
|
|
HDAC4
|
histone deacetylase 4
|
|
HFE
|
hemochromatosis
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNF1A
|
HNF1 homeobox A
|
|
HOXD13
|
homeobox D13
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGHM
|
immunoglobulin heavy constant mu
|
|
IGHV4-34
|
immunoglobulin heavy variable 4-34
|
|
IGLL1
|
immunoglobulin lambda-like polypeptide 1
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL7R
|
interleukin 7 receptor
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INPP5E
|
inositol polyphosphate-5-phosphatase, 72 kDa
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
ITS
|
Insulinoma tumor suppressor gene locus
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
|
KCNAB2
|
potassium channel, voltage gated subfamily A regulatory beta subunit 2
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KDR
|
kinase insert domain receptor
|
|
KIF11
|
kinesin family member 11
|
|
KIF1B
|
kinesin family member 1B
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLHDC8B
|
kelch domain containing 8B
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT1
|
keratin 1, type II
|
|
KRT10
|
keratin 10, type I
|
|
KRT14
|
keratin 14, type I
|
|
KRT16
|
keratin 16, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT6B
|
keratin 6B, type II
|
|
KRT9
|
keratin 9, type I
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
L2HGDH
|
L-2-hydroxyglutarate dehydrogenase
|
|
LEMD3
|
LEM domain containing 3
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LMNA
|
lamin A/C
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing
|
|
LRRC8A
|
leucine rich repeat containing 8 family, member A
|
|
LRRFIP2
|
leucine rich repeat (in FLII) interacting protein 2
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MAGT1
|
magnesium transporter 1
|
|
MALT1
|
MALT1 paracaspase
|
|
MAMLD1
|
mastermind-like domain containing 1
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCC
|
mutated in colorectal cancers
|
|
MCF2
|
MCF.2 cell line derived transforming sequence
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT2
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
|
|
MINPP1
|
multiple inositol-polyphosphate phosphatase 1
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLH1
|
mutL homolog 1
|
|
MLH3
|
mutL homolog 3
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MT-TF
|
tRNA
|
|
MT-TH
|
tRNA
|
|
MT-TK
|
tRNA
|
|
MT-TL1
|
tRNA
|
|
MT-TP
|
tRNA
|
|
MT-TQ
|
tRNA
|
|
MT-TS1
|
tRNA
|
|
MT-TS2
|
tRNA
|
|
MT-TW
|
tRNA
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTM1
|
myotubularin 1
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal
|
|
NBEAL2
|
neurobeachin-like 2
|
|
NBN
|
nibrin
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
ND1
|
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor)
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NHP2
|
NHP2 ribonucleoprotein
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOP10
|
NOP10 ribonucleoprotein
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRTN
|
neurturin
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NSUN2
|
NOP2/Sun RNA methyltransferase family, member 2
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
OCA2
|
oculocutaneous albinism II
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX3
|
paired box 3
|
|
PAX7
|
paired box 7
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCM1
|
pericentriolar material 1
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDGFRL
|
platelet-derived growth factor receptor-like
|
|
PHB
|
prohibitin
|
|
PHF21A
|
PHD finger protein 21A
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIEZO2
|
piezo-type mechanosensitive ion channel component 2
|
|
PIGL
|
phosphatidylinositol glycan anchor biosynthesis, class L
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNP
|
purine nucleoside phosphorylase
|
|
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLR1C
|
polymerase (RNA) I polypeptide C, 30kDa
|
|
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa
|
|
PORCN
|
porcupine homolog (Drosophila)
|
|
POT1
|
protection of telomeres 1
|
|
POU6F2
|
POU class 6 homeobox 2
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP2R1B
|
protein phosphatase 2, regulatory subunit A, beta
|
|
PRCC
|
papillary renal cell carcinoma (translocation-associated)
|
|
PRDM16
|
PR domain containing 16
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PTCH1
|
patched 1
|
|
PTCH2
|
patched 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAD51C
|
RAD51 paralog C
|
|
RAD54B
|
RAD54 homolog B (S. cerevisiae)
|
|
RAD54L
|
RAD54-like (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RECQL4
|
RecQ protein-like 4
|
|
RET
|
ret proto-oncogene
|
|
RHBDF2
|
rhomboid 5 homolog 2 (Drosophila)
|
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF139
|
ring finger protein 139
|
|
RNF6
|
ring finger protein (C3H2C3 type) 6
|
|
RNR1
|
RNA, ribosomal cluster 1
|
|
RPGRIP1L
|
RPGRIP1-like
|
|
RPL11
|
ribosomal protein L11
|
|
RPL15
|
ribosomal protein L15
|
|
RPL26
|
ribosomal protein L26
|
|
RPL35A
|
ribosomal protein L35a
|
|
RPL5
|
ribosomal protein L5
|
|
RPS10
|
ribosomal protein S10
|
|
RPS14
|
ribosomal protein S14
|
|
RPS17
|
ribosomal protein S17
|
|
RPS19
|
ribosomal protein S19
|
|
RPS24
|
ribosomal protein S24
|
|
RPS26
|
ribosomal protein S26
|
|
RPS29
|
ribosomal protein S29
|
|
RPS7
|
ribosomal protein S7
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEC23A
|
Sec23 homolog A (S. cerevisiae)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SETBP1
|
SET binding protein 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFTPA2
|
surfactant protein A2
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SHOX
|
short stature homeobox
|
|
SKI
|
SKI proto-oncogene
|
|
SLC22A18
|
solute carrier family 22, member 18
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC26A2
|
solute carrier family 26 (anion exchanger), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SRD5A3
|
steroid 5 alpha-reductase 3
|
|
SRP72
|
signal recognition particle 72kDa
|
|
SRY
|
sex determining region Y
|
|
SSTR5
|
somatostatin receptor 5
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
STK4
|
serine/threonine kinase 4
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFG
|
TRK-fused gene
|
|
TG
|
thyroglobulin
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THPO
|
thrombopoietin
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TMC6
|
transmembrane channel-like 6
|
|
TMC8
|
transmembrane channel-like 8
|
|
TMEM67
|
transmembrane protein 67
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPBG
|
trophoblast glycoprotein
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRIM33
|
tripartite motif containing 33
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSG101
|
tumor susceptibility 101
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYR
|
tyrosinase
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
USB1
|
U6 snRNA biogenesis 1
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VANGL2
|
VANGL planar cell polarity protein 2
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WHSC1L1
|
Wolf-Hirschhorn syndrome candidate 1-like 1
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XGR
|
XG and CD99 regulator
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
ZNF35
|
zinc finger protein 35
|